Part 4: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection
Data files
Sep 11, 2025 version files 1.18 GB
-
1_24_MDAMB231_FLORO-1.mzML
25.80 MB
-
10_24_MDAMB231_toxo-1.mzML
25.53 MB
-
11_24_MDAMB231_toxo-2.mzML
26.30 MB
-
12_24_MDAMB231_toxo-3.mzML
26.23 MB
-
13_24_MDAMB231_KO-1.mzML
25.89 MB
-
14_24_MDAMB231_KO-2.mzML
25.20 MB
-
15_24_MDAMB231_KO-3.mzML
25.54 MB
-
16_24_MDAMB231_KO_toxo-1.mzML
25.01 MB
-
17_24_MDAMB231_KO_toxo-2.mzML
25.29 MB
-
18_24_MDAMB231_KO_toxo-3.mzML
25.69 MB
-
19_48_MDAMB231_FLORO-1.mzML
24.73 MB
-
2_24_MDAMB231_FLORO-2.mzML
27.61 MB
-
20_48_MDAMB231_FLORO-2.mzML
25.21 MB
-
21_48_MDAMB231_FLORO-3.mzML
25.40 MB
-
22_48_MDAMB231_FLORO_toxo-1.mzML
25.42 MB
-
23_48_MDAMB231_FLORO_toxo-2.mzML
25.69 MB
-
24_48_MDAMB231_FLORO_toxo-3.mzML
25.50 MB
-
25_48_MDAMB231-1.mzML
26.02 MB
-
26_48_MDAMB231-2.mzML
25.64 MB
-
27_48_MDAMB231-2.mzML
25.76 MB
-
28_48_MDAMB231_toxo-1.mzML
25.77 MB
-
29_48_MDAMB231_toxo-2.mzML
25.77 MB
-
3_24_MDAMB231_FLORO-3.mzML
26.65 MB
-
30_48_MDAMB231_toxo-3.mzML
26.50 MB
-
31_48_MDAMB231_KO1-1.mzML
25.40 MB
-
32_48_MDAMB231_KO1-2.mzML
25.34 MB
-
33_48_MDAMB231_KO1-3.mzML
25.40 MB
-
34_48_MDAMB231_KO1_toxo-1.mzML
25.76 MB
-
35_48_MDAMB231_KO1_toxo-2.mzML
25.47 MB
-
36_48_MDAMB231_KO1_toxo-3.mzML
26.07 MB
-
4_24_MDAMB231_FLORO_toxo-1.mzML
25.63 MB
-
5_24_MDAMB231_FLORO_toxo-2.mzML
26.25 MB
-
6_24_MDAMB231_FLORO_toxo-3.mzML
26.06 MB
-
7_24_MDAMB231-1.mzML
26.43 MB
-
8_24_MDAMB231-2.mzML
25.67 MB
-
9_24_MDAMB231-3.mzML
25.71 MB
-
AMP_10uM.mzML
24.90 MB
-
dGMP_10uM.mzML
24.22 MB
-
GDP_10uM.mzML
24.95 MB
-
GMP_10uM.mzML
25.04 MB
-
GTP_10uM.mzML
25.05 MB
-
Guanosine_10uM.mzML
24.33 MB
-
IMP_10uM.mzML
24.03 MB
-
Inosine_10uM.mzML
24.46 MB
-
PreBlnk1.mzML
29.85 MB
-
PreBlnk2.mzML
26.77 MB
-
README.md
7.34 KB
Abstract
Intracellular bacteria and protists rely on the host cell to supply many metabolites, but the mechanisms through which pathogens manipulate host metabolism to their benefit are not understood. Here, we demonstrate that when the obligate intracellular parasite Toxoplasma gondii secretes its rhoptry organelle contents into the host cytoplasm before invasion—a process called “kiss and spit”—host cell metabolite abundance is altered in nucleotide synthesis, the pentose phosphate pathway, glycolysis, and amino acid synthesis. U-13C6 labeling metabolomics confirmed that kiss and spit increased the flow of carbon through the pentose phosphate pathway and nucleotide synthesis. An increase in 2,3-bisphosphoglycerate abundance led us to investigate the activation of host cytosolic nucleosidase II (cN-II) to provide purines for the parasite. We found that T. gondii manipulates the host cN-II enzyme to dephosphorylate GMP and IMP that it needs for replication. Further, we found that the approved anti-cancer drug fludarabine, which inhibits cN-II, also inhibits Toxoplasma replication. These results reveal Toxoplasma host cell manipulation and highlight potential therapies for toxoplasmosis.
There are several datasets related to T. gondii kiss and spit
Part 1: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.b2rbnzsjd : Time course of T. gondii kiss and spit-HFF cells metabolomics
Part 2: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.69p8cz9b5: U-13C6 labeling of ME49 T. gondii kiss and spit and full infection in HFF cells
Part 3: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.9p8cz8wrn: Effect of fludarabine on purine metabolism in T. gondii infected HFF host cells
Part 4: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.7d7wm383s: ME49T. gondii infected MDAMB231 cells Metabolomics at 24 and 48 HPI
Part 5: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.ghx3ffbxx: Effect of AMP addition on purine metabolism in T. gondii infected host cells at 48 HPI
Part 6: Kiss and spit metabolomics highlight the role of host purine metabolism during pathogen infection: 10.5061/dryad.zkh1893jn: ME49 T. gondii Kiss and spit negative controls
https://doi.org/10.5061/dryad.7d7wm383s
Description of the data and file structure
The following samples were run in triplicate:
MDAMB231 : uninfected MDAM231231 parental cell line
MDAMB231_FLORO: uninfected MDAMB231 parental cell line plus Fludarabine
MDAMB231_toxo: ME49 T. gondii infected MDAM231231 parental cell line
MDAMB231_KO: uninfectedcMDAM231231 Cytosolic nucleotidase II (cN-II) Knock-out cell line
MDAMB231_KO_toxo: ME49 T. gondii infected MDAM231231Cytosolic nucleotidase II (cN-II) Knock-out cell line
24 HPI ( samples from 1-17) or 48 HPI (samples from 18-36) time point are included in the sample name. Pre-blank samples and standards at 10 uM are included.
| 1_24_MDAMB231_FLORO-1.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 1 |
|---|---|
| 2_24_MDAMB231_FLORO-2.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 2 |
| 3_24_MDAMB231_FLORO-3.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 3 |
| 4_24_MDAMB231_FLORO_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 1 |
| 5_24_MDAMB231_FLORO_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 2 |
| 6_24_MDAMB231_FLORO_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 24 H, replicate 3 |
| 7_24_MDAMB231-1.mzML | Uninfected MDAMB231 cell line for 24 H, replicate 1 |
| 8_24_MDAMB231-2.mzML | Uninfected MDAMB231 cell line for 24 H, replicate 2 |
| 9_24_MDAMB231-3.mzML | Uninfected MDAMB231 cell line for 24 H, replicate 3 |
| 10_24_MDAMB231_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cell line for 24 H, replicate 1 |
| 11_24_MDAMB231_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cell line for 24 H, replicate 2 |
| 12_24_MDAMB231_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cell line for 24 H, replicate 3 |
| 13_24_MDAMB231_KO-1.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 1 |
| 14_24_MDAMB231_KO-2.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 2 |
| 15_24_MDAMB231_KO-3.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 3 |
| 16_24_MDAMB231_KO_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 1 |
| 17_24_MDAMB231_KO_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 2 |
| 18_24_MDAMB231_KO_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 24 H, replicate 3 |
| 19_48_MDAMB231_FLORO-1.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 1 |
| 20_48_MDAMB231_FLORO-2.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 2 |
| 21_48_MDAMB231_FLORO-3.mzML | Uninfected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 3 |
| 22_48_MDAMB231_FLORO_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 1 |
| 23_48_MDAMB231_FLORO_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 2 |
| 24_48_MDAMB231_FLORO_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cell line treated with Fludarabine for 48 H, replicate 3 |
| 25_48_MDAMB231-1.mzML | Uninfected MDAMB231 cell line for 48 H, replicate 1 |
| 26_48_MDAMB231-2.mzML | Uninfected MDAMB231 cell line for 48 H, replicate 2 |
| 27_48_MDAMB231-2.mzML | Uninfected MDAMB231 cell line for 48 H, replicate 3 |
| 28_48_MDAMB231_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cell line for 48 H, replicate 1 |
| 29_48_MDAMB231_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cell line for 48 H, replicate 2 |
| 30_48_MDAMB231_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cell line for 48 H, replicate 3 |
| 31_48_MDAMB231_KO1-1.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 48 H, replicate 1 |
| 32_48_MDAMB231_KO1-2.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 48 H, replicate 2 |
| 33_48_MDAMB231_KO1-3.mzML | Uninfected MDAMB231 cN-II Knock-out cell line for 48 H, replicate 3 |
| 34_48_MDAMB231_KO1_toxo-1.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 48H, replicate 1 |
| 35_48_MDAMB231_KO1_toxo-2.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 48H, replicate 2 |
| 36_48_MDAMB231_KO1_toxo-3.mzML | ME49 T. gondii-infected MDAMB231 cN-II Knock-out cell line for 48H, replicate 3 |
| AMP_10uM.mzML | AMP standard at 10 uM |
| dGMP_10uM.mzML | dGMP standard at 10 uM |
| GDP_10uM.mzML | GDP standard at 10 uM |
| GMP_10uM.mzML | GMP standard at 10 uM |
| GTP_10uM.mzML | GTP standard at 10 uM |
| Guanosine_10uM.mzML | Guanosine standard at 10 uM |
| IMP_10uM.mzML | IMP standard at 10 uM |
| Inosine_10uM.mzML | Inosine standard at 10 uM |
| PreBlnk1.mzML | Blank sample |
| PreBlnk2.mzML | blank sample |
Code/Software
Peaks were matched to known standards for identification. Data analysis was performed using the Metabolomics Analysis and Visualization Engine (MAVEN) software
To understand the role of cN-II in T. gondii infection, we performed metabolomics on the uninfected and T. gondii- infected MDAMB231 parental and cN-II KO cell lines at 24 and 48 HPI. IMP and GMP, the preferred substrates of the cN-II enzyme, tended to accumulate in infected cells in comparison to uninfected cells, with the exception of GMP at 24 HPI in cN-II KO cells . The nucleobase products of the cN-II reaction, inosine, guanosine, were significantly less abundant or not detected in infected cells at 24 HPI. Inosine and guanosine were lower in abundance in T. gondii-infected cN-II KO cell lines with respect to the infected MDAMB231 parental line at 48 HPI. Thus, the genetic deletion of cN-II enzyme affected the metabolites IMP, GMP, inosine and guanosine in infected cells.
MDAMB231 or MDAMB231 KO dishes in triplicate were infected with 2 x 106 ME49 tachyzoites. We used as negative controls dishes of uninfected cells. At 24 and 48 HPI, dishes were washed three times with ice cold PBS, then quenched with 80:20 HPLC grade Methanol: Water (Sigma-Aldrich). Dishes were incubated on dry ice at -80°C for 15 minutes. Plates were scraped, the solution removed, and spun at 2500 x g for 5 minutes at 4°C. The supernatant was removed and stored on ice, then the pellet was washed again in quenching solution and re-spun. Supernatants were combined, dried down under N2, and stored at -80°C.
Samples were resuspended in 100 µL HPLC grade water (Fisher Optima) for analysis on a Thermo-Fisher Vanquish Horizon UHPLC coupled to an electrospray ionization source (HESI) part of a hybrid quadrupole-Orbitrap high resolution mass spectrometer (Q Exactive Orbitrap; Thermo Scientific). Chromatography was performed using a 100 mm x 2.1 mm x 1.7 µm BEH C18 column (Acquity) at 30°C. 20 µL of the sample was injected via an autosampler at 4°C and flow rate was 200 µL/min. Solvent A was 97:3 water/methanol with 10 mM tributylamine (TBA) (Sigma-Aldrich) adjusted to a pH of 8.2 using approximately 9 mM Acetate (final concentration, Sigma-Aldrich). Solvent B was 100% methanol with no TBA (Sigma- Aldrich). Products were eluted in 95% A / 5% B for 2.5 minutes, then a gradient of 95% A / 5% B to 5% A / 95% B over 14.5 minutes, then held for an additional 2.5 minutes at 5%A / 95%B. Finally, the gradient was returned to 95% A / 5% B over 0.5 minutes and held for 5 minutes to re-equilibrate the column. MS parameters included: scan in negative mode; scan range = 70 - 1000 m/z; Automatic Gain control (AGC) = 1e6, spray voltage = 3.0 kV, maximum ion collection time = 40 ms, and capillary temperature = 350C. Peaks were matched to known standards for identification. Data analysis was performed using the Metabolomics Analysis and Visualization Engine (MAVEN) software
